Big Pharma Faceoff: Wegovy To Join Mounjaro In India’s Booming Weight Loss Drug Market

While both drugs belong to the GLP-1 receptor agonist class, Mounjaro has a dual mechanism (GIP and GLP-1), which clinical trials suggest may provide superior weight loss outcomes

India